Related references
Note: Only part of the references are listed.
Review
Rheumatology
Mrinalini Dey et al.
Summary: Despite improved treatment for RA, around 30% of patients continue to experience symptoms, referred to as 'difficult-to-treat' (D2T) RA. Comorbidities are recognized as significant contributors to D2T disease and are perpetuated by the D2T state.
Article
Immunology
Tao-tao Zhou et al.
Summary: In this study, the shared key genes between rheumatoid arthritis (RA) and major depressive disorder (MDD) were identified through gene expression analysis and protein-protein interaction network. Machine learning techniques determined six diagnostic markers associated with both diseases, and molecular docking and in vitro experiments validated the therapeutic potential of two markers.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Rheumatology
Sijia Fang et al.
Summary: This study investigated the association between depression and rheumatoid arthritis (RA) using meta-analyses and found no causal relationship between the two diseases, suggesting that the links might be due to shared environmental confounders.
CLINICAL RHEUMATOLOGY
(2023)
Article
Rheumatology
Gyorgy Nagy et al.
Summary: The EULAR Task Force developed evidence-based points to consider for the management of difficult-to-treat rheumatoid arthritis, covering diagnostic confirmation, evaluation of inflammatory disease activity, pharmacological and non-pharmacological interventions, treatment adherence, functional disability, pain, fatigue, goal setting, self-efficacy, and impact of comorbidities. The strength of recommendations varied from level C to D, with a generally high level of agreement.
ANNALS OF THE RHEUMATIC DISEASES
(2022)
Review
Immunology
Mitsuhiro Akiyama et al.
Summary: Rheumatoid arthritis is an autoimmune disease that primarily affects the joints but can also lead to interstitial lung disease. Understanding the pathogenesis and clinical features of this condition is crucial for better management and improved prognosis. Currently, there is no established treatment strategy specifically for RA-ILD.
AUTOIMMUNITY REVIEWS
(2022)
Article
Rheumatology
Pierre-Antoine Juge et al.
Summary: This study developed and validated a risk score to identify high-risk patients of subclinical RA-ILD, with findings supporting an important contribution of MUC5B rs35705950 to the risk of subclinical RA-ILD.
ARTHRITIS & RHEUMATOLOGY
(2022)
Review
Health Care Sciences & Services
Laura Slagter et al.
Summary: This systematic literature review found that mind-body therapies, including meditation, mindfulness, and yoga, have beneficial effects on patients with rheumatoid arthritis, especially for those with depressive symptoms.
JOURNAL OF PERSONALIZED MEDICINE
(2022)
Review
Rheumatology
Gyorgy Nagy et al.
Summary: The Task Force aimed to create recommendations for the underserved patient group with difficult-to-treat rheumatoid arthritis by drafting a definition based on international survey data among rheumatologists, nurses, health professionals, and patients. The definition includes specific criteria for treatment failure and symptom characteristics that are considered problematic by both the healthcare provider and the patient. This proposed EULAR definition can be applied in clinical practice, trials, and serve as a foundation for future research.
ANNALS OF THE RHEUMATIC DISEASES
(2021)
Review
Behavioral Sciences
Daniela Bavaresco et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
(2020)
Review
Psychiatry
Louis Nerurkar et al.
